trial · primary record
Adaptive Hypofractionated Radiotherapy
Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 264 |
| Primary completion | 2030-05 |
| Primary endpoint | Physician-reported Grade 2+ toxicity |
| Registry ID | NCT07516210 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:10.535Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07516210
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.